Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
0(0%)
Results Posted
20%(1 trials)
Terminated
1(17%)

Phase Distribution

Ph phase_4
2
33%
Ph phase_2
2
33%
Ph phase_3
1
17%

Phase Distribution

0

Early Stage

2

Mid Stage

3

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
2(40.0%)
Phase 3Large-scale testing
1(20.0%)
Phase 4Post-market surveillance
2(40.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(5)
Terminated(1)

Detailed Status

Completed5
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
83.3%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (40.0%)
Phase 31 (20.0%)
Phase 42 (40.0%)

Trials by Status

completed583%
terminated117%

Recent Activity

0 active trials
Showing 5 of 6
completedphase_4

Efficacy, Safety, Preference and Response Duration of Clobex® Spray and Taclonex® Ointment in Psoriasis

NCT00437255
completed

Efficacy, Tolerance and Satisfaction With CLOBEX® Spray When Used as Monotherapy or Add-on Therapy in Plaque Psoriasis

NCT00437216
terminatedphase_2

Progesterone vs Clobetasol Propionate in Vulvar Lichen Sclerosus

NCT01126255
completedphase_2

Effect of Bifidobacterium Animalis Subsp. Lactis HN019 on Oral Lichen Planus

NCT03386643
completedphase_4

Ethanol-Free Clobetasol Propionate Foam 0.05% (Olux-E Foam) vs Vehicle Foam in the Treatment of Chronic Hand Dermatitis.

NCT01323673
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT00437255Phase 4

Efficacy, Safety, Preference and Response Duration of Clobex® Spray and Taclonex® Ointment in Psoriasis

Completed
NCT00437216

Efficacy, Tolerance and Satisfaction With CLOBEX® Spray When Used as Monotherapy or Add-on Therapy in Plaque Psoriasis

Completed
NCT01126255Phase 2

Progesterone vs Clobetasol Propionate in Vulvar Lichen Sclerosus

Terminated
NCT03386643Phase 2

Effect of Bifidobacterium Animalis Subsp. Lactis HN019 on Oral Lichen Planus

Completed
NCT01323673Phase 4

Ethanol-Free Clobetasol Propionate Foam 0.05% (Olux-E Foam) vs Vehicle Foam in the Treatment of Chronic Hand Dermatitis.

Completed
NCT01453686Phase 3

A Trial of Clobetasol Propionate Versus Hydrocortisone in Children With Alopecia Areata

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6